Trials / Conditions / Metastatic Pancreatic Neuroendocrine Tumor
Metastatic Pancreatic Neuroendocrine Tumor
5 registered clinical trials studyying Metastatic Pancreatic Neuroendocrine Tumor — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Study to Test the Combination of Fulvestrant With Lu-DOTATATE for Advanced Pancreatic Neuroendocrine Tumors NCT06663072 | University of Chicago | Phase 1 |
| Recruiting | Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine NCT05687123 | National Cancer Institute (NCI) | Phase 1 |
| Active Not Recruiting | Comparing Capecitabine and Temozolomide in Combination to Lutetium Lu 177 Dotatate in Patients With Advanced P NCT05247905 | Alliance for Clinical Trials in Oncology | Phase 2 |
| Completed | Survivin Long Peptide Vaccine in Treating Patients With Metastatic Neuroendocrine Tumors NCT03879694 | Roswell Park Cancer Institute | Phase 1 |
| Active Not Recruiting | Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors NCT03375320 | National Cancer Institute (NCI) | Phase 3 |